Binding selectivity of conformationally restricted analogues of (−)-indolactam-v to the c1 domains of protein kinase C isozymes

Bioscience, Biotechnology and Biochemistry

Volumn 66, Issue 7, 2002, Pages 1615-1617

  Masuda, Akiko ^a   Irie, Kazuhiro ^a   Nakagawa, Yu ^a   Ohigashi, Hajime ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

( ) indolactam V; Isozyme selective binding; Phorbol ester; Protein kinase C; Tumor promoter

Indexed keywords

INDOLACTAM V; INDOLE DERIVATIVE; ISOENZYME; LACTAM; PROTEIN KINASE C;

ARTICLE; KINETICS; METABOLISM; PROTEIN CONFORMATION;

INDOLES; ISOENZYMES; KINETICS; LACTAMS; PROTEIN CONFORMATION; PROTEIN KINASE C;

EID: 0036654782     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.66.1615     Document Type: Article

References (11)

1. Nishizuka, Y., Protein kinase C and lipid signaling for sustained cellular responses. FASEB J., 9, 484-496 (1995).
2. Goekjian, P. G., and Jirousek, M. R., Protein kinase C in the treatment of disease: signal transduction pathways, inhibitors, and agents in development. Curr. Med. Chem., 6, 877-903 (1999).
3. Hurley, J. H., Newton, A. C., Parker, P. J., Blumberg, P. M., and Nishizuka, Y., Taxonomy and function of C1 protein kinase C homology domains. Protein Sci., 6, 477-480 (1997).
4. Shindo, M., Irie, K., Nakahara, A., Ohigashi, H., Konishi, H., Kikkawa, U., Fukuda, H., and Wender, P. A., Toward the identification of selective modulators of protein kinase C (PKC) isozymes: establishment of a binding assay for PKC isozymes using synthetic C1 peptide receptors and identification of the critical residues involved in the phorbol ester binding. BioMed. Chem., 9, 2073-2081 (2001).
5. Irie, K., Hirota, M., Hagiwara, N., Koshimizu, K., Hayashi, H., Murao, S., Tokuda, H., and Ito, Y., The Epstein-Barr virus early antigen inducing indole alkaloids, (-)-indolactam-V and its related compounds produced by Actinomycetes. Agric. Biol. Chem., 48, 1269-1274 (1984).
6. Endo, Y., Shudo, K., Itai, A., Hasegawa, M., and Sakai, S., Synthesis and stereochemistry of indolac-tam-V, an active fragment of teleocidins. Structural requirements for tumor-promoting activity. Tetrahedron, 42, 5905-5924 (1986).
7. Nakagawa, Y., Irie, K., Ohigashi, H., Hayashi, H., and Wender, P. A., Synthesis and PKC isozyme surrogate binding of indothiolactam-V, a new thioamide analogue of tumor promoting indolactam-V. BioMed. Chem. Lett., 10, 2087-2090 (2000).
8. Irie, K., Isaka, T., Iwata, Y., Yanai, Y., Nakamura, Y., Koizumi, F., Ohigashi, H., Wender, P. A., Satomi, Y., and Nishino, H., Synthesis and biological activities of new conformationally restricted analogues of (-)-indolactam-V: elucidation of the biologically active conformation of the tumor-promoting teleocidins. J. Am. Chem. Soc., 118, 10733-10743 (1996).
9. Kazanietz, M. G., Areces, L. B., Bahador, A., Mischak, H., Goodnight, J., Mushinski, J. F., and Blumberg, P. M., Characterization of ligand and substrate specificity for the calcium-dependent and calcium-independent protein kinase C isozymes. Mol. Pharmacol., 44, 298-307 (1993).
10. Setterblad, N., Onyango, I., Pihlgren, U., Rask, L., and Andersson, G., The role of protein kinase C signaling in activated DRA transcription. J. Immunol., 161, 4819-4824 (1998).
11. Barry, O. P., and Kazanietz, M. G., Protein kinase C isozymes, novel phorbol ester receptors and cancer chemotherapy, Curr. Pharm. Design, 7, 1725-1744 (2001).